More Algorae Pharmaceuticals Limited news
Algorae Pharmaceuticals LimitedASX: 1AI

Quarterly Activities Report/Appendix 4C Cash Flow Statement

Jan 29, 2024 at 10:51 PM EST · Issued by Algorae Pharmaceuticals Limited

Filed with ASX · Jan 29, 2024 at 10:51 PM EST

On 6ix: 6ix.com/news/quarterly-activities-reportappendix-4c-cash-flow-statement

Algorae Pharmaceuticals Limited has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Algorae Pharmaceuticals Limited on 6ix

Story so far

  • Quarterly Activities/Appendix 5B Cash Flow ReportOct 27, 2023
  • Quarterly Activities/Appendix 4C Cash Flow ReportJul 28, 2023

Earlier from Algorae Pharmaceuticals

  • Agreement with HL Pharma AddendumJan 4, 2024
  • Algorae to list existing Option series on ASXDec 5, 2023
  • 1AI commences AI-168 pre-clinical studiesNov 22, 2023
  • Addendum to September Quarterly ReportNov 21, 2023
  • CSIRO Grant for Artificial Intelligence PlatformOct 30, 2023

Later from Algorae Pharmaceuticals

  • NTCELL Project UpdateFeb 14, 2024
  • Response to ASX Price QueryFeb 20, 2024
  • Artificial Intelligence Platform UpdateMar 7, 2024
  • Positive results from AI-116 in vitro studiesJul 30, 2024
  • AlgoraeOS Artificial Intelligence Platform LaunchedSep 23, 2024
All Algorae Pharmaceuticals news releases↗

Follow Algorae Pharmaceuticals into a list and get an email when it puts out news.

Follow Algorae Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer